Mts Medications (AMEX:MPP)
Historical Stock Chart
From Jun 2019 to Jun 2024
MTS Medication Technologies, Inc. (AMEX:MPP) (www.mts-mt.com)
today announced that there has been significant progress in the
acceptance of OnDemand machines by its largest customer. During the past
weeks, there have been several additional Express II’s™
and an AccuFlex® machine accepted. Also, other
acceptance tests of both Express II and AccuFlex machines are being
concluded and are expected to result in additional machines continuing
to be accepted.
The Company will release its fourth quarter and fiscal year-end
financial results for period ended March 31, 2008 after the market
closes on Monday, June 30, 2008.
Management of the Company will host a conference call on Tuesday, July
1, 2008 at 8:30 AM EDT to discuss the Company’s
earnings, financial results and achievements, which will be followed by
a question and answer session with professional investors. Private
investors are encouraged to e-mail their questions in advance of the
conference call to ir@mts-mt.com or
by facsimile to 727-579-8067.
To access the conference call please telephone 888-459-5609 and enter
52522025 for the conference ID number. A digital replay will be
available and may be accessed by visiting the Company’s
web site at www.mts-mt.com.
About MTS Medication Technologies
Founded in 1984, MTS Medication Technologies (www.mts-mt.com)
is an international provider of medication compliance packaging systems
designed to improve medication dispensing and administration. MTS
manufactures automated packaging machines and related consumables for
prescription medications and nutritional supplements. The Company serves
more than 8,000 pharmacies worldwide.
This press release contains forward-looking information made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements may be
affected by certain risks and uncertainties described in the Company’s
filings with the Securities and Exchange Commission (SEC) and actual
results could differ materially from those set forth in forward-looking
statements. Statements contained herein that are not historical
facts are forward-looking statements and may include, but are not
limited to, projections of revenue, income or losses, the value of
contracts, capital expenditures, plans for future operations, the
elimination of losses under certain programs, financing needs or plans,
compliance with financial covenants in loan agreements, plans for sale
of assets or businesses, plans relating to products or services of the
Company, assessments of materiality, predictions of future events and
the effects of pending and possible litigation, as well as assumptions
relating to the foregoing. Other factors that could affect such
differences include, but are not limited to, unanticipated increases in
operating costs, labor disputes, capital requirements, increases in
borrowing costs, product demand, pricing, market acceptance,
intellectual property rights and litigation, risks in product and
technology development and other risk factors detailed in the Company’s
SEC filings. All statements regarding the marketing program
resulting in increased sales are forward looking statements. Readers
are cautioned not to place undue reliance on any forward-looking
statements. The Company undertakes no obligation to publicly
release the result of any revisions of these forward-looking statements
that may be made to reflect events or circumstances after the date
hereof or to reflect the occurrence of unexpected events.